News + Updates

Drs. Jenny Lo-Ciganic and Ted Park have been awarded a new R01 from NIH/NIDA for PRIME-OUD, a project to develop an AI-assisted clinical decision support tool that helps primary care providers...

Katie Suda has been awarded two new grants from NIA to advance CP3’s drug shortages research program. SUPPLY-US, a new R01, will examine the severity and duration of drug shortages, comparing patterns...

Congratulations to CP3's Jing Luo on a new R01 award from National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

The study, OFF-RAMP Feasibility, will examine how patients can safely...

Congratulations to CP3's Tim Anderson and Ted Park, Co-Investigators on a newly funded R01: "Use and effectiveness of medications for opioid use disorder in older adults with multimorbidity."

Opioid...

CP3's Dr. Tim Anderson was a guest on the GeriPal podcast to discuss when to start or stop statins in older adults. Drawing on his role as the American Geriatrics Society representative on the 2026...

CP3 is proud to support a new Postdoctoral Research Fellowship in Optimizing Addiction Pharmacotherapy, offered through VA Pittsburgh Healthcare System in partnership with the University of Pittsburgh...

We are pleased to welcome back Inma Hernandez, PhD, former CP3 Associate Director, for a seminar on pharmaceutical policy and drug pricing.

Dr. Hernandez currently serves as Senior Advisor for Drug...

The University of Pittsburgh's General Internal Medicine fellowship applications are now open for programs starting July 2027. Deadline to apply is September 10th.

Clinician-Researcher Fellowship: a...

A study led by CP3's Tim Anderson on how the 2026 AHA/ACC dyslipidemia guideline expands statin eligibility for primary prevention has drawn wide national media coverage since its publication in JAMA...

New research from CP3's Tim Anderson, published today in JAMA, finds that more than half of U.S. adults ages 30 to 79 (about 87.5 million people) are now recommended for statins under updated...